Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Yeo, Winnie; C. Chan, Tung; W.Y. Leung, Nancy; Y. Lam, Wai; K.F. Mo, Frankie; Ting Chu, Miu; L.Y. Chan, Henry; P. Hui, Edwin; I.K. Lei, Kenny; S.K. Mok, Tony; K.S. Chan, Paul

doi:10.1200/jco.2008.18.0182

Public

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Shared by NobleBlocks on Feb 1, 2009 • 12:00 AM UTC

Authors:

Winnie Yeo

Tung C. Chan

Nancy W.Y. Leung

Abstract

Purpose Reactivation of hepatitis B virus (HBV) infection is a well-recognized complication in cancer patients with chronic HBV (hepatitis B surface antigen [HBsAg] positive) undergoing cytotoxic chemotherapy. In patients who have resolved HBV (HBsAg negative and antibody to hepatitis B core antigen...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!